Organoids as Oracles for Precision Medicine in Rectal Cancer
- PMID: 31951587
- DOI: 10.1016/j.stem.2019.12.003
Organoids as Oracles for Precision Medicine in Rectal Cancer
Abstract
Two recent papers in Cell Stem Cell and Nature Medicine (Yao et al. [2019] and Ganesh et al. [2019]) demonstrate the successful use of rectal cancer patient-derived organoids to predict patient responses to neoadjuvant chemoradiation therapy, paving the way toward a new paradigm for precision medicine.
Copyright © 2019 Elsevier Inc. All rights reserved.
Comment on
-
A rectal cancer organoid platform to study individual responses to chemoradiation.Nat Med. 2019 Oct;25(10):1607-1614. doi: 10.1038/s41591-019-0584-2. Epub 2019 Oct 7. Nat Med. 2019. PMID: 31591597 Free PMC article.
-
Patient-Derived Organoids Predict Chemoradiation Responses of Locally Advanced Rectal Cancer.Cell Stem Cell. 2020 Jan 2;26(1):17-26.e6. doi: 10.1016/j.stem.2019.10.010. Epub 2019 Nov 21. Cell Stem Cell. 2020. PMID: 31761724
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
